AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2017
Jun 20, 2017
34395_dirs_2017-06-20_8e5cb4ae-d216-4353-91c1-704360c3edf0.zip
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-06-13
Reporting Person: Gaetan Michel (Manager Belgian Volition SPRL)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No securities are beneficially owned. | 0 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $2.5 | 2019-02-18 | Common Stock (2500) | Direct | |
| Stock Option (Right to Buy) | $3 | 2020-02-18 | Common Stock (2500) | Direct | |
| Stock Option (Right to Buy) | $4 | 2020-01-23 | Common Stock (2000) | Direct |